Bio-Techne
TECH
#1410
Rank
โ‚น1.069 T
Marketcap
โ‚น6,742
Share price
5.03%
Change (1 day)
15.10%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚น35.19 B

According to Bio-Techne's latest financial reports the company's total debt is โ‚น35.19 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30โ‚น37.33 B45.05%
2022-06-30โ‚น25.73 B-17.63%
2021-06-30โ‚น31.24 B-4.58%
2020-06-30โ‚น32.74 B-5.98%
2019-06-30โ‚น34.83 B50.11%
2018-06-30โ‚น23.20 B4.45%
2017-06-30โ‚น22.21 B245.8%
2016-06-30โ‚น6.42 B30.99%
2015-06-30โ‚น4.90 B530.88%
2014-06-30โ‚น0.77 B
2006-06-30โ‚น0.62 B-2.27%
2005-06-30โ‚น0.63 B-12.73%
2004-06-30โ‚น0.72 B-7.89%
2003-06-30โ‚น0.79 B-10.23%
2002-06-30โ‚น0.88 B-0.9%
2001-06-30โ‚น0.89 B1.03%
2000-06-30โ‚น0.88 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
โ‚น2.970 T 8,339.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น116.83 B 231.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.621 T 4,505.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.427 T 3,954.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น117.58 B 234.09%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚น1.650 T 4,589.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.60 B-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA